Showing results (1351-1360 of 1,520) with videos related to
Sort By:
Pageof 152
International Journal of Pediatric Otorhinolaryngology|February 21, 2006
Four mutations in Epidermodysplasia verruciformis 1 (EVER1) gene are not contributors to susceptibility in RRPJoseph Donfack, Farrel J Buchinsky, Craig S Derkay, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II StudyMark N Polizzotto, Thomas S Uldrick, Kathleen M Wyvill, et al.Molecular Interventions|January 18, 2008
Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practiceRobert Kinders, Ralph E Parchment, Jay Ji, et al.Clinical Colorectal Cancer|April 12, 2015
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal CancerKhanh Do, Liang Cao, Zhigang Kang, et al.Oncotarget|August 4, 2016
Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trialChristopher R Heery, Ravi A Madan, Mark N Stein, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2G A Ohnmacht, G Q Phan, S A Mavroukakis, et al.Menopause (New York, N.Y.)|December 6, 2012
Effect of soy isoflavone supplementation on menopausal quality of lifePaula Amato, Ronald L Young, Francene M Steinberg, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 27, 2019
Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional studyReed I Ayabe, Raja R Narayan, Samantha M Ruff, et al.The Oncologist|March 26, 2017
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi SarcomaThomas S Uldrick, Priscila H Gonçalves, Kathleen M Wyvill, et al.Journal of Dental Research|June 16, 2012
Oral chronic graft-vs.-host disease characterization using the NIH scaleH Fassil, C W Bassim, J Mays, et al.Pageof 152